PCN19 A COST-CONSEQUENCE ANALYSIS OF DARBEPOETIN ALFA ADMINISTERED EVERY 3 WEEKS (Q3W DA) COMPARED TO WEEKLY EPOETIN ALFA (QW EA) OR EPOETIN BETA (QW EB) IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA (CIA)-THE GERMAN CASE
Abstract
Authors
LA Van Bellinghen G Esposito M Lamotte A Braceo A Goertz L Annemans